Gaido K W, Maness S C, McDonnell D P, Dehal S S, Kupfer D, Safe S
Chemical Industry Institute of Toxicology, Research Triangle Park, North Carolina, USA.
Mol Pharmacol. 2000 Oct;58(4):852-8.
We previously demonstrated differential interactions of the methoxychlor metabolite 2,2-bis(p-hydroxyphenyl)-1,1, 1-trichloroethane (HPTE) with estrogen receptor alpha (ERalpha), ERbeta, and the androgen receptor (AR). In this study, we characterize the ERalpha, ERbeta, and AR activity of structurally related methoxychlor metabolites. Human hepatoma cells (HepG2) were transiently transfected with human ERalpha, ERbeta, and AR plus an appropriate steroid-responsive luciferase reporter vector. After transfection, cells were treated with various concentrations of HPTE or structurally related compounds in the presence (for detecting antagonism) and absence (for detecting agonism) of 17beta-estradiol and dihydrotestosterone. The monohydroxy analog of methoxychlor, as well as monohydroxy and dihydroxy analogs of 2, 2-bis(p-hydroxyphenyl)-1,1-dichloroethylene, had ERalpha agonist activity and ERbeta and AR antagonist activity similar to HPTE. The trihydroxy metabolite of methoxychlor displayed only weak ERalpha agonist activity and did not alter ERbeta or AR activities. Replacement of the trichloroethane or dichloroethylene group with a methyl group resulted in a compound with ERalpha and ERbeta agonist activity that retained antiandrogenic activities. This study identifies some of the structural requirements for ERalpha and ERbeta activity and demonstrates the complexity involved in determining the mechanism of action of endocrine-active chemicals that simultaneously act as agonists or antagonists through one or more hormone receptors.
我们之前证明了甲氧滴滴涕代谢物2,2-双(对羟基苯基)-1,1,1-三氯乙烷(HPTE)与雌激素受体α(ERα)、雌激素受体β(ERβ)和雄激素受体(AR)之间存在差异相互作用。在本研究中,我们对结构相关的甲氧滴滴涕代谢物的ERα、ERβ和AR活性进行了表征。用人ERα、ERβ和AR以及合适的类固醇反应性荧光素酶报告载体瞬时转染人肝癌细胞(HepG2)。转染后,在存在(用于检测拮抗作用)和不存在(用于检测激动作用)17β-雌二醇和二氢睾酮的情况下,用不同浓度的HPTE或结构相关化合物处理细胞。甲氧滴滴涕的单羟基类似物以及2,2-双(对羟基苯基)-1,1-二氯乙烯的单羟基和二羟基类似物具有与HPTE相似的ERα激动活性以及ERβ和AR拮抗活性。甲氧滴滴涕的三羟基代谢物仅表现出较弱的ERα激动活性,且不改变ERβ或AR活性。用甲基取代三氯乙烷或二氯乙烯基团会产生一种具有ERα和ERβ激动活性且保留抗雄激素活性的化合物。本研究确定了ERα和ERβ活性的一些结构要求,并证明了在确定通过一种或多种激素受体同时充当激动剂或拮抗剂的内分泌活性化学物质的作用机制时所涉及的复杂性。